KSHV RTA: more than viral replication
KSHV RTA: more than viral replication
批准号:
8460154
负责人:
Jae U Jung
金额:
$28.17万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-01 至 2016-05-31
关键词:
AcetylationAffectAnimal ModelAntibody FormationBacterial Artificial ChromosomesCallithrix jacchus jacchusCancer EtiologyCellsCharacteristicsChromatinChromatin Remodeling FactorChromatin StructureCircular DNAComplicationDNADeubiquitinationDevelopmentDrug resistanceEpigenetic ProcessEventGene ExpressionGene Expression RegulationGenesGeneticGenomeGenome StabilityGoalsGrantHIV InfectionsHIV-1HerpesviridaeHerpesviridae InfectionsHeterochromatinHighly Active Antiretroviral TherapyHistonesHumanHuman Herpesvirus 8In VitroIncidenceInfectionKaposi SarcomaLesionLeukocytesLifeLymphomaLyticMalignant NeoplasmsMalignant lymphoid neoplasmMethylationModelingModificationMulticentric Angiofollicular Lymphoid HyperplasiaMusNucleosomesOralOutcomePathogenesisPatientsPatternPlayPleural effusion disorderPolycombPost-Translational Protein ProcessingPrimatesProcessProteinsRaceRecombinantsRegulationResearchRoleRouteStressStructureTimeTranscriptional RegulationUbiquitinationViralViral GenesVirusVirus Latencyarmbacterial geneticsbasegenetic manipulationgenome-widehistone modificationin vivoinnovationlatent gene expressionlytic gene expressionlytic replicationprogramsreactivation from latencytooltranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ever since their existence, there has been an everlasting arms race between viruses and their host cells. Host cells have developed numerous strategies to silence viral gene expression, whereas viruses always find ways to overcome these obstacles. Accordingly, viruses have evolved to take full advantage of existing cellular chromatin components to activate or repress its own genes when needed. In fact, host epigenetic modifications of the herpesviral genome chromatin play a key role in the transcriptional control of latent and lytic genes during a productive viral lifecycle. Kaposi's sarcoma-associated herpesvirus (KSHV) is a ubiquitous herpesvirus that establishes a life-long persistent infection in humans and is associated with Kaposi's sarcoma and several lymphoid malignancies. During latency, the KSHV genome persists as a multicopy circular DNA assembled into nucleosomal structures. While viral latency is characterized by restricted viral gene expression, reactivation induces the lytic replication program and the expression of viral genes in a defined sequential and temporal order. Our preliminary study demonstrates that (1) the latent and lytic chromatins of KSHV are associated with a distinctive pattern of activating and repressive histone modifications whose distribution changes upon reactivation in an organized manner in correlation with the temporally ordered expression of viral lytic genes. Furthermore, (2) the evolutionarily conserved Polycomb group proteins and histone deubiquitinases also play a critical role in the regulation of KSHV latency and reactivation by regulating the viral chromatin structure. Thus, the epigenetic program of KSHV is at the crux of restricting latent gene expression and the orderly expression of lytic genes. The goal of this study is to better understand how epigenetic modifications of the KSHV genome affect viral latency and lytic replication, to thereby contribute to the development of a persistent infection and subsequent pathogenic events in vivo. Based on our preliminary studies, we hypothesize that the proper epigenetic regulation of the KSHV genome is critical for viral persistency during latency and reactivation, and for pathogenesis in KSHV infected lesions. This proposal is highly innovative, utilizing well-established comprehensive genome-wide ChIP array, BAC genetics, and in vivo experimental conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
-
批准号:10784250
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2023
-
负责人:Jae U Jung
-
依托单位:
Reassortment of Bunyavirus in ticks and animal models
-
批准号:10512873
-
项目类别:
-
资助金额:$59.31万
-
财政年份:2022
-
负责人:Jae U Jung
-
依托单位:
Reassortment of Bunyavirus in ticks and animal models
-
批准号:10686796
-
项目类别:
-
资助金额:$57.78万
-
财政年份:2022
-
负责人:Jae U Jung
-
依托单位:
KSHV Epigenetic Regulation
-
批准号:10293613
-
项目类别:
-
资助金额:$43.12万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHV Epigenetic Regulation
-
批准号:10312714
-
项目类别:
-
资助金额:$43.12万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
-
批准号:10413218
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Tickborne SFTS Virus Vaccine Development
-
批准号:10670989
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHVmediated regulation of proline metabolism
-
批准号:10293612
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Tickborne SFTS Virus Vaccine Development
-
批准号:10227961
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Tickborne SFTS Virus Vaccine Development
-
批准号:10451811
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
-
批准号:10643706
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Regulation of lymphangiogenesis by KSHV vIRF3
-
批准号:10252172
-
项目类别:
-
资助金额:$12.43万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHVmediated regulation of proline metabolism
-
批准号:10312715
-
项目类别:
-
资助金额:$46.3万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHV Epigenetic Regulation
-
批准号:10252377
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHVmediated regulation of proline metabolism
-
批准号:10267964
-
项目类别:
-
资助金额:$18.84万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
-
批准号:10030628
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHVmediated regulation of proline metabolism
-
批准号:10521249
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHV Epigenetic Regulation
-
批准号:10521293
-
项目类别:
-
资助金额:$43.12万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
-
批准号:10254390
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
SFTSV nonstructural protein NSs-mediated immunopathogenesis
-
批准号:10441349
-
项目类别:
-
资助金额:$60.42万
-
财政年份:2018
-
负责人:Jae U Jung
-
依托单位:
海外基金